These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 24408882)

  • 1. Feasibility and efficacy of the 2.5 L and 3.8 L impella percutaneous left ventricular support device during high-risk, percutaneous coronary intervention in patients with severe aortic stenosis.
    Spiro J; Venugopal V; Raja Y; Ludman PF; Townend JN; Doshi SN
    Catheter Cardiovasc Interv; 2015 May; 85(6):981-9. PubMed ID: 24408882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous retrograde left ventricular assist support for interventions in patients with aortic stenosis and left ventricular dysfunction.
    Martinez CA; Singh V; Londoño JC; Cohen MG; Alfonso CE; O'Neill WW; Heldman AW
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1201-9. PubMed ID: 22511541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Balloon Aortic Valvuloplasty Followed by Impella®-Assisted Left Main Coronary Artery Percutaneous Coronary Intervention in Patients With Severe Aortic Stenosis as a Bridge to Transcatheter Aortic Valve Replacement.
    Diaz Quintero L; Gajo E; Guerrero M; Feldman T; Levisay J
    Cardiovasc Revasc Med; 2021 Jan; 22():16-21. PubMed ID: 32532627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elective Mechanical Circulatory Support in the Percutaneous Treatment of Patients With Combined Complex Coronary Artery Disease and Severe Aortic Valve Stenosis.
    Briguori C; Focaccio A; D'Amore C; Selvetella L; Lonobile T
    J Invasive Cardiol; 2019 Mar; 31(3):52-56. PubMed ID: 30819975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bail-Out Use of Impella CP as a Bridge to TAVI in a Cardiogenic Shock Patient: The "Pump-Rewiring" Technique.
    Burzotta F; Nerla R; Trani C
    J Invasive Cardiol; 2016 Jan; 28(1):E1-5. PubMed ID: 26716594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protected Percutaneous Coronary Intervention of Unprotected Left Main Using Impella Ventricular Assist Device Before Transcatheter Aortic Valve Implantation: A Single-Center Experience.
    Kneizeh K; Alnaimi A; Noterdaeme T; Schröder J; Altiok E; Marx N; Almalla M
    J Invasive Cardiol; 2022 Mar; 34(3):E196-E201. PubMed ID: 35058376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Balloon aortic valvuloplasty in high risk aortic stenosis patients with left ventricular ejection fractions <20%.
    Pedersen WR; Goldenberg IF; Pedersen CW; Lesser A; Harris KM; Lesser JR; Garberich RF; Schwartz JG; Shank E; Schwartz RS
    Catheter Cardiovasc Interv; 2014 Nov; 84(5):824-31. PubMed ID: 24323518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic support using the Impella 2.5 catheter system during high-risk percutaneous coronary intervention in a patient with severe aortic stenosis.
    Harjai KJ; O'Neill WW
    J Interv Cardiol; 2010 Feb; 23(1):66-9. PubMed ID: 20040004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience.
    Dixon SR; Henriques JP; Mauri L; Sjauw K; Civitello A; Kar B; Loyalka P; Resnic FS; Teirstein P; Makkar R; Palacios IF; Collins M; Moses J; Benali K; O'Neill WW
    JACC Cardiovasc Interv; 2009 Feb; 2(2):91-6. PubMed ID: 19463408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impella support following emergency percutaneous balloon aortic valvuloplasty in patients with severe aortic valve stenosis and cardiogenic shock.
    Karatolios K; Chatzis G; Luesebrink U; Markus B; Ahrens H; Tousoulis D; Schieffer B
    Hellenic J Cardiol; 2019; 60(3):178-181. PubMed ID: 29571667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications and outcome of balloon aortic valvuloplasty in high-risk or inoperable patients.
    Ben-Dor I; Pichard AD; Satler LF; Goldstein SA; Syed AI; Gaglia MA; Weissman G; Maluenda G; Gonzalez MA; Wakabayashi K; Collins SD; Torguson R; Okubagzi P; Xue Z; Kent KM; Lindsay J; Waksman R
    JACC Cardiovasc Interv; 2010 Nov; 3(11):1150-6. PubMed ID: 21087751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry.
    Sjauw KD; Konorza T; Erbel R; Danna PL; Viecca M; Minden HH; Butter C; Engstrøm T; Hassager C; Machado FP; Pedrazzini G; Wagner DR; Schamberger R; Kerber S; Mathey DG; Schofer J; Engström AE; Henriques JP
    J Am Coll Cardiol; 2009 Dec; 54(25):2430-4. PubMed ID: 20082934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in aortic valve area using a new "hour glass" shaped valvuloplasty balloon compared with standard cylindrical balloons in severe aortic stenosis patients.
    Pedersen WR; Mooney MR; Ungs D; Pedersen C; Sorajja P; Poulose AK; Stark RP; Murad B; Garberich RF; Goldenberg E; Schwartz RS
    Minerva Cardioangiol; 2014 Jun; 62(3):243-9. PubMed ID: 24831760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study?
    Syed AI; Kakkar A; Torguson R; Li Y; Ben-Dor I; Collins SD; Lemesle G; Maluenda G; Xue Z; Scheinowitz M; Kaneshige K; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Cardiovasc Revasc Med; 2010; 11(2):91-7. PubMed ID: 20347798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel therapeutic aspects of percutaneous aortic valve replacement with the 21F CoreValve Revalving System.
    Berry C; Asgar A; Lamarche Y; Marcheix B; Couture P; Basmadjian A; Ducharme A; Laborde JC; Cartier R; Bonan R
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):610-6. PubMed ID: 17894307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and long-term safety of elective Impella-assisted high-risk percutaneous coronary intervention: a pilot two-centre study.
    Burzotta F; Paloscia L; Trani C; Mascellanti M; Mongiardo R; Materazzo G; Niccoli G; Di Marco M; Leone AM; Porto I; Mazzari MA; Rebuzzi AG; Schiavoni G; Crea F
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1004-10. PubMed ID: 18799962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic support with Impella ventricular assist device in patients undergoing TAVI: A single center experience.
    Almalla M; Kersten A; Altiok E; Marx N; Schröder JW
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):357-362. PubMed ID: 31268621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-hospital and long-term outcomes of percutaneous balloon aortic valvuloplasty with concomitant percutaneous coronary intervention in patients with severe aortic stenosis.
    Daniec M; Sorysz D; Dziewierz A; Kleczyński P; Rzeszutko Ł; Krawczyk-Ożóg A; Dudek D
    J Interv Cardiol; 2018 Feb; 31(1):60-67. PubMed ID: 28833508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of hemodynamic support with Impella in very high-risk patients undergoing balloon aortic valvuloplasty: Results from the Global cVAD Registry.
    Singh V; Yadav PK; Eng MH; Macedo FY; Silva GV; Mendirichaga R; Badiye AP; Sakhuja R; Elmariah S; Inglessis I; Alfonso CE; Schreiber TL; Cohen M; Palacios I; O'Neill WW
    Int J Cardiol; 2017 Aug; 240():120-125. PubMed ID: 28377189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic outcomes of transcatheter aortic valve replacement and medical management in severe, inoperable aortic stenosis: a longitudinal echocardiographic study of cohort B of the PARTNER trial.
    Douglas PS; Hahn RT; Pibarot P; Weissman NJ; Stewart WJ; Xu K; Wang Z; Lerakis S; Siegel R; Thompson C; Gopal D; Keane MG; Svensson LG; Tuzcu EM; Smith CR; Leon MB
    J Am Soc Echocardiogr; 2015 Feb; 28(2):210-7.e1-9. PubMed ID: 25455544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.